GAPLINC and colorectal cancer: Secondly, they can be targeted with higher specificity than other small molecules.13 For instance, the recently identified GAPLINC is a 924‐bp lncRNA, that is involved in different types of cancer.14, 15, 16, 17 In gastric cancer and colorectal cancer, GAPLINC competes with CD44 for miR‐211, and higher expression of GAPLINC was found to be correlated with large tumour size.14 High expression of GAPLINC increases cell migration and vessel formation.